O Shaughnessy Asset Management LLC lifted its holdings in Colgate-Palmolive (NYSE:CL) by 40.3% in the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 16,962 shares of the company’s stock after purchasing an additional 4,875 shares during the period. O Shaughnessy Asset Management LLC’s holdings in Colgate-Palmolive were worth $1,380,000 at the end of the most recent reporting period.
Several other hedge funds have also made changes to their positions in the stock. BlackRock Inc. grew its holdings in shares of Colgate-Palmolive by 5.1% in the first quarter. BlackRock Inc. now owns 61,053,242 shares of the company’s stock valued at $4,812,829,000 after purchasing an additional 2,946,033 shares in the last quarter. Massachusetts Financial Services Co. MA lifted its stake in Colgate-Palmolive by 9.5% in the first quarter. Massachusetts Financial Services Co. MA now owns 40,166,201 shares of the company’s stock worth $3,166,302,000 after acquiring an additional 3,475,832 shares during the last quarter. Geode Capital Management LLC lifted its stake in Colgate-Palmolive by 1.6% in the first quarter. Geode Capital Management LLC now owns 13,967,241 shares of the company’s stock worth $1,098,365,000 after acquiring an additional 216,446 shares during the last quarter. Arrowstreet Capital Limited Partnership lifted its stake in Colgate-Palmolive by 306.9% in the first quarter. Arrowstreet Capital Limited Partnership now owns 6,263,673 shares of the company’s stock worth $493,765,000 after acquiring an additional 4,724,331 shares during the last quarter. Finally, Nuveen Asset Management LLC lifted its stake in Colgate-Palmolive by 2.2% in the first quarter. Nuveen Asset Management LLC now owns 5,944,407 shares of the company’s stock worth $468,598,000 after acquiring an additional 128,030 shares during the last quarter. Hedge funds and other institutional investors own 76.28% of the company’s stock.
CL stock opened at $77.38 on Tuesday. The company has a fifty day moving average price of $80.05 and a 200 day moving average price of $80.26. Colgate-Palmolive has a 12 month low of $74.14 and a 12 month high of $86.41. The company has a market cap of $65.27 billion, a price-to-earnings ratio of 24.26, a price-to-earnings-growth ratio of 3.98 and a beta of 0.60. The company has a debt-to-equity ratio of 9.22, a current ratio of 1.11 and a quick ratio of 0.70.
The firm also recently declared a quarterly dividend, which will be paid on Monday, November 15th. Investors of record on Thursday, October 21st will be given a $0.45 dividend. This represents a $1.80 annualized dividend and a yield of 2.33%. Colgate-Palmolive’s dividend payout ratio (DPR) is 58.82%.
In other Colgate-Palmolive news, Director Lorrie M. Norrington sold 1,898 shares of the business’s stock in a transaction on Wednesday, August 4th. The shares were sold at an average price of $78.02, for a total value of $148,081.96. Following the transaction, the director now directly owns 24,602 shares of the company’s stock, valued at approximately $1,919,448.04. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Jennifer Daniels sold 20,290 shares of the business’s stock in a transaction on Thursday, August 5th. The shares were sold at an average price of $79.11, for a total transaction of $1,605,141.90. The disclosure for this sale can be found here. 0.32% of the stock is owned by corporate insiders.
A number of brokerages recently issued reports on CL. Evercore ISI reiterated a “buy” rating and issued a $95.00 price target on shares of Colgate-Palmolive in a research note on Sunday, June 20th. Credit Suisse Group upgraded shares of Colgate-Palmolive from a “neutral” rating to an “outperform” rating and lifted their price target for the stock from $80.00 to $95.00 in a research note on Wednesday, June 9th. Deutsche Bank Aktiengesellschaft decreased their price target on shares of Colgate-Palmolive from $86.00 to $84.00 and set a “hold” rating for the company in a research note on Monday, August 2nd. Finally, UBS Group started coverage on shares of Colgate-Palmolive in a research report on Wednesday, June 23rd. They set a “buy” rating and a $95.00 price objective for the company. Two research analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $85.54.
Colgate-Palmolive Co is engaged in the manufacturing and distribution of consumer products. It operates through Oral, Personal and Home Care and Pet Nutrition segments. The Oral, Personal and Home Care segment represents North America, Latin America, Europe, Asia Pacific, and Africa or Eurasia, all of which sell to a variety of retail and wholesale customers and distributors.
Featured Story: What Are Cryptocurrencies?
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.